本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

葛兰素史克

38.79
+0.36420.95%
成交量:177.36万
成交额:6,855.34万
市值:791.09亿
市盈率:24.91
高:38.86
开:38.40
低:38.37
收:38.43
数据加载中...

公司资料

公司名字:
葛兰素史克
交易所:
NYSE
成立时间:
1715
员工人数:
68629
公司地址:
980 Great West Road,Middlesex,Brentford,Greater London,United Kingdom
邮编:
TW8 9GS
传真:
- -
简介:
GSK Plc于1999年12月6日在英国成立的公众服务有限公司,是一个世界领先的研究型制药和保健公司,由 Glaxo Wellcome plc和SmithKline Beecham plc合并而成。公司致力于开发较现有治疗方案明显改善的新产品,为病人和政府、保险公司或其他第三方提供帮助。

董事

名称
职位
Andrew Witty
director and Chief Executive Officer
Christopher Gent
Chairman
Jean Stephenne
Chairman and President, Biologicals
Marc Dunoyer
Global Head, GSK Rare Diseases and Chairman of GSK Japan
Moncef Slaoui
Chairman, Research & Development,Non-Executive Director
Crispin Davis
Non-Executive Director
Daniel Podolsky
Non-Executive Director
Deryck Maughan
Non-Executive Director
Gavin Screaton
Non-Executive Director
James Murdoch
Non-Executive Director
Judy C. Lewent
Non-Executive Director
Larry Culp
Non-Executive Director
Robert Wilson
Non-Executive Director
Roy Anderson
Non-Executive Director
Simon Dingemans
director and Chief Financial Officer
Stacey Cartwright
Non-Executive Director
Stephanie A. Burns
Non-Executive Director
Tom de Swaan
Non-Executive Director

股东

名称
职位
Andrew Witty
director and Chief Executive Officer
Bill Louv
Senior Vice President, Core Business Services & Chief Information Officer
Claire Thomas
Senior Vice President, Human Resources
Dan Troy
Senior Vice President and General Counsel
Phil Thomson
Senior Vice President, Global Communications
Simon Bicknell
Senior Vice President, Governance, Ethics and Assurance
Simon Dingemans
director and Chief Financial Officer
Abbas Hussain
President, Emerging Markets & Asia Pacific
David Pulman
President, Global Manufacturing and Supply
David Redfern
Chief Strategy Officer
Deirdre P. Connelly
President, North America Pharmaceuticals
Eddie Gray
President, Pharmaceuticals Europe
Emma Walmsley
President, Consumer Healthcare Worldwide
Jean Stephenne
Chairman and President, Biologicals
John Clarke
President, Consumer Healthcare Worldwide
Marc Dunoyer
Global Head, GSK Rare Diseases and Chairman of GSK Japan
Moncef Slaoui
Chairman, Research & Development,Non-Executive Director
Patrick Vallance
President, Pharmaceuticals R&D